tiprankstipranks
Trending News
More News >
MoonLake Immunotherapeutics (MLTX)
NASDAQ:MLTX
US Market

MoonLake Immunotherapeutics (MLTX) Income Statement

Compare
643 Followers

MoonLake Immunotherapeutics Income Statement

Last quarter (Q4 2025), MoonLake Immunotherapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, MoonLake Immunotherapeutics's net income was $-62.43M. See MoonLake Immunotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -2.62M$ 0.00$ 0.00$ 0.00$ -4.97K
Operating Expenses
$ 242.22M$ 143.09M$ 54.12M$ 65.06M$ 53.57M
Depreciation and Amortization
$ 2.62M$ 1.38M$ 370.32K$ 164.78K$ 4.97K
EBITDA
$ -219.85M$ -141.71M$ -53.75M$ -64.90M$ -53.63M
Operating Income
$ -244.83M$ -143.09M$ -54.12M$ -65.06M$ -53.58M
Other Income/Expenses
$ 15.12M$ 22.13M$ 10.14M$ 591.73K$ -61.85K
Pretax Income
$ -229.71M$ -120.96M$ -43.98M$ -64.47M$ -53.64M
Net Income
$ -227.32M$ -118.94M$ -36.01M$ -49.97M$ -53.64M
Per Share Metrics
Basic EPS
$ -3.53$ -1.89$ -0.73$ -2.20$ -1.45
Diluted EPS
$ -3.53$ -1.89$ -0.73$ -2.20$ -1.45
Weighted Average Shares Outstanding
64.46M 62.87M 49.12M 29.36M 36.93M
Weighted Average Shares Outstanding (Diluted)
64.46M 62.87M 49.12M 29.36M 36.93M
Currency in USD

MoonLake Immunotherapeutics Earnings and Revenue History